U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula 2C16H31O2.Ca
Molecular Weight 550.91
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of CALCIUM PALMITATE

SMILES

[Ca++].CCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCC([O-])=O

InChI

InChIKey=HRBZRZSCMANEHQ-UHFFFAOYSA-L
InChI=1S/2C16H32O2.Ca/c2*1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16(17)18;/h2*2-15H2,1H3,(H,17,18);/q;;+2/p-2

HIDE SMILES / InChI

Molecular Formula Ca
Molecular Weight 40.078
Charge 2
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula C16H31O2
Molecular Weight 255.4161
Charge -1
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

PubMed

PubMed

TitleDatePubMed
Gbeta gamma isoforms selectively rescue plasma membrane localization and palmitoylation of mutant Galphas and Galphaq.
2001-06-29
Demonstration of direct effects of growth hormone on neonatal cardiomyocytes.
2001-06-22
Insulin inhibits peroxisomal fatty acid oxidation in isolated rat hepatocytes.
2001-06
Systemic and regional free fatty acid metabolism in type 2 diabetes.
2001-06
Physiological levels of mammalian uncoupling protein 2 do not uncouple yeast mitochondria.
2001-05-25
[Branched alkanes and other apolar compounds produced by the cyanobacterium Microcoleus vaginatus from the Negev desert].
2001-05-19
Differential palmitoylation of two mouse glutamate receptor interacting protein 1 forms with different N-terminal sequences.
2001-05-18
Biochemical characterization of the reverse activity of rat brain ceramidase. A CoA-independent and fumonisin B1-insensitive ceramide synthase.
2001-05-18
Identification and quantitation of unique fatty acid oxidation products in human atherosclerotic plaque using high-performance liquid chromatography.
2001-05-15
Palmitoylation of caveolin-1 in endothelial cells is post-translational but irreversible.
2001-05-11
Palmitate-induced apoptosis can occur through a ceramide-independent pathway.
2001-05-04
Thiazolidinediones increase plasma-adipose tissue FFA exchange capacity and enhance insulin-mediated control of systemic FFA availability.
2001-05
Chronic valproate treatment decreases the in vivo turnover of arachidonic acid in brain phospholipids: a possible common effect of mood stabilizers.
2001-05
Heparin-induced release of protein-bound solutes during hemodialysis is an in vitro artifact.
2001-05
Effects of lung surfactant proteins, SP-B and SP-C, and palmitic acid on monolayer stability.
2001-05
Effects of free fatty acids on beta-cell functions: a possible involvement of peroxisome proliferator-activated receptors alpha or pancreatic/duodenal homeobox.
2001-05
Imaging of monolayers composed of palmitic acid and lung surfactant protein B.
2001-05
The sites for fatty acylation, phosphorylation and intermolecular disulphide bond formation of influenza C virus CM2 protein.
2001-05
A high-sucrose diet increases gluconeogenic capacity in isolated periportal and perivenous rat hepatocytes.
2001-05
n-6 and n-3 polyunsaturated fatty acids differentially modulate oncogenic Ras activation in colonocytes.
2001-05
Plasma membrane localization of palmitoylated tubulin.
2001-04-27
Induction of apoptosis through B-cell receptor cross-linking occurs via de novo generated C16-ceramide and involves mitochondria.
2001-04-27
Kinetics of the lipase-catalyzed synthesis of glucose esters in acetone.
2001-04-20
Thioacylation is required for targeting G-protein subunit G(o1alpha) to detergent-insoluble caveolin-containing membrane domains.
2001-04-15
Pulmonary surfactant protein SP-B is significantly more immunoreactive in anionic than in zwitterionic bilayers.
2001-04-13
Regulation of surfactant-like particle secretion by Caco-2 cells.
2001-04-02
Tolerance induction by acylated peptides: suppression of EAE in the mouse with palmitoylated PLP peptides.
2001-04-02
Fatty acid and triglyceride composition of milk fat from lactating Holstein cows in response to supplemental canola oil.
2001-04
Effect of gamma-butyrobetaine on fatty liver in juvenile visceral steatosis mice.
2001-04
Identification of fatty acid molecules in a Fasciola hepatica immunoprophylactic fatty acid-binding protein.
2001-04
Effects of authentic and VLDL hydrolysis-derived fatty acids on vascular smooth muscle cell growth.
2001-04
Carotenoid esters in vegetables and fruits: a screening with emphasis on beta-cryptoxanthin esters.
2001-04
Uncoupling protein 2: a possible link between fatty acid excess and impaired glucose-induced insulin secretion?
2001-04
Continuous fatty acid oxidation and reduced fat storage in mice lacking acetyl-CoA carboxylase 2.
2001-03-30
Regulation of G proteins by covalent modification.
2001-03-26
Expression of rat liver long-chain acyl-CoA synthetase and characterization of its role in the metabolism of R-ibuprofen and other fatty acid-like xenobiotics.
2001-03-15
Anaerobic biodegradation of alkanes by enriched consortia under four different reducing conditions.
2001-03
Optimization of methods and treatment conditions for studying effects of fatty acids on cell growth.
2001-03
Effects of diets enriched in n-6 or n-3 fatty acids on cholesterol metabolism in older rats chronically fed a cholesterol-enriched diet.
2001-03
Brain and hippocampus fatty acid composition in phospholipid classes of aged-relative cognitive deficit rats.
2001-03
Gas chromatographic analysis of total fatty acids in cider.
2001-03
Modelling of hexadecane degradation in continuous-flow cultures.
2001-03
Effects of antiinflammatory triterpenes isolated from Leptadenia hastata latex on keratinocyte proliferation.
2001-03
Participation of carnitine palmitoyltransferase in the synthesis of dipalmitoylphosphatidylcholine in rat alveolar type II cells.
2001-02
A stearic acid-rich diet improves thrombogenic and atherogenic risk factor profiles in healthy males.
2001-02
Fatty acid-induced apoptosis in neonatal cardiomyocytes: redox signaling.
2001-02
Lipotoxicity of the pancreatic beta-cell is associated with glucose-dependent esterification of fatty acids into neutral lipids.
2001-02
Myocardial fatty acid oxidation in patients with impaired glucose tolerance.
2001-02
Effect of fatty acids on phase behavior of hydrated dipalmitoylphosphatidylcholine bilayer: saturated versus unsaturated fatty acids.
2001-02
L-carnitine reduces malondialdehyde concentrations in isolated rat hearts in dependence on perfusion conditions.
2001-01
Patents
Substance Class Chemical
Created
by admin
on Mon Mar 31 21:55:23 GMT 2025
Edited
by admin
on Mon Mar 31 21:55:23 GMT 2025
Record UNII
5792C4VMFZ
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
CALCIUM PALMITATE
MI  
Systematic Name English
CALCIUM PALMITATE [MI]
Preferred Name English
PALMITIC ACID, CALCIUM SALT
Common Name English
INS NO.470(I)PALMITIC ACID, CALCIUM SALT
Common Name English
INS NO-470(I)PALMITIC ACID, CALCIUM SALT
Common Name English
INS-470(I)PALMITIC ACID, CALCIUM SALT
Common Name English
E-470(I)PALMITIC ACID, CALCIUM SALT
Common Name English
HEXADECANOIC ACID, CALCIUM SALT (2:1)
Systematic Name English
Classification Tree Code System Code
JECFA EVALUATION INS-470(I)
Created by admin on Mon Mar 31 21:55:23 GMT 2025 , Edited by admin on Mon Mar 31 21:55:23 GMT 2025
CODEX ALIMENTARIUS (GSFA) INS-470(I)
Created by admin on Mon Mar 31 21:55:23 GMT 2025 , Edited by admin on Mon Mar 31 21:55:23 GMT 2025
Code System Code Type Description
PUBCHEM
9829021
Created by admin on Mon Mar 31 21:55:23 GMT 2025 , Edited by admin on Mon Mar 31 21:55:23 GMT 2025
PRIMARY
CAS
542-42-7
Created by admin on Mon Mar 31 21:55:23 GMT 2025 , Edited by admin on Mon Mar 31 21:55:23 GMT 2025
PRIMARY
ECHA (EC/EINECS)
208-811-3
Created by admin on Mon Mar 31 21:55:23 GMT 2025 , Edited by admin on Mon Mar 31 21:55:23 GMT 2025
PRIMARY
EPA CompTox
DTXSID6027189
Created by admin on Mon Mar 31 21:55:23 GMT 2025 , Edited by admin on Mon Mar 31 21:55:23 GMT 2025
PRIMARY
MERCK INDEX
m2959
Created by admin on Mon Mar 31 21:55:23 GMT 2025 , Edited by admin on Mon Mar 31 21:55:23 GMT 2025
PRIMARY Merck Index
SMS_ID
300000054639
Created by admin on Mon Mar 31 21:55:23 GMT 2025 , Edited by admin on Mon Mar 31 21:55:23 GMT 2025
PRIMARY
DAILYMED
5792C4VMFZ
Created by admin on Mon Mar 31 21:55:23 GMT 2025 , Edited by admin on Mon Mar 31 21:55:23 GMT 2025
PRIMARY
FDA UNII
5792C4VMFZ
Created by admin on Mon Mar 31 21:55:23 GMT 2025 , Edited by admin on Mon Mar 31 21:55:23 GMT 2025
PRIMARY